Ashley Braddom
Ph.D. Student
Ashley’s research focuses on understanding the role of B cells in the protective immune response to Plasmodium falciparum, the causative agent of malaria.
Ashley earned a B.S. in molecular genetics from The Ohio State University where she began her research career by studying the role of microRNAs in skin cancer development. As a graduate student, she is excited to continue building her research skills while learning about malaria and its interactions with the immune system. After graduate school, she hopes to study emerging infectious diseases and their treatment in developing, resource-poor areas. In my free time, she enjoys running on the trails around San Antonio.
Education
B.S., Molecular Genetics with honors in the arts and sciences and honors research distinction, The Ohio State University, 2018
Awards
1st place, Best Oral Presentation, 8th Annual Vaccine Development Center of San Antonio Conference, November 2019.
Publications
D’Avino C, Palmieri D, Braddom A, Zanesi N, James C, Cole S, Salvatore F, Croce C, De Lorenzo C. A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy. Oncotarget. 2016; 7: 87016-30
Palmieri D, Scarpa M, Tessari A, Uka R, Amari F, Lee C, Richmond T, Sheetz T, Braddom A, Burd C, Parvin J, Ludwig T, Croce C, and Coppola V. Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells. Oncotarget. 2016; 7: 18371-83.